Iron infusion to improve recovery after gynecologic cancer surgery
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This Phase 3 study tests whether giving a specific iron medicine before major gynecologic cancer surgery can improve recovery. It’s mainly for people with low blood counts from low iron stores before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and can sign consent
- You’re scheduled for planned major gynecologic oncology surgery that lasts 1 hour or more
- Your surgery is expected within 28 to 90 days after joining the study
- Your pre-surgery blood test shows low hemoglobin (<120 g/L) and low iron saturation (TSAT <20%)
- You can receive the study infusion at least 21 days but no more than 90 days before surgery
- If you can become pregnant, you must have a negative pregnancy test and use reliable birth control through the study and for 6 weeks after the infusion
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving iron (iron sucrose) can reduce anemia during chemotherapy before curative surgery. It may help you feel better and have smoother treatment by improving low blood counts caused by iron deficiency.
This study tests whether giving an iron infusion before surgery can improve outcomes for people with gastric cancer who are going to have their stomach removed. The goal is to see if it helps with recovery or reduces complications.
This study tests whether giving an iron infusion after heart surgery can prevent long-term anemia (low blood counts). It aims to help patients recover better and avoid needing blood transfusions later.
This trial tests whether giving iron directly into the bloodstream before surgery improves recovery for people with colorectal cancer who have low iron but are not anemic. It may help reduce fatigue and the need for blood transfusions after surgery.
This study tests whether giving a combination of iron, a hormone that boosts red blood cells, and a medication to reduce bleeding before surgery can help patients with bone tumors who have low iron or anemia. It aims to improve recovery and reduce the need for blood transfusions after surgery.
This trial tests whether giving an intravenous iron supplement (ferric derisomaltose) can help prevent anemia and improve quality of life in obese patients who have low iron stores. It aims to see if this treatment can boost energy and reduce fatigue.
Hear when a new Gynecologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.